
簡(jiǎn)要描述:Lacosamide 175481-36-4Lacosamide (Vimpat; Erlosamide) is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.
產(chǎn)品分類(lèi)
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 175481-36-4 |
|---|---|---|---|
| 分子式 | C13H18N2O3 | 純度 | 98% |
| 分子量 | 250.29 | 貨號(hào) | abs47028075 |
| 規(guī)格 | 250mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | is a medication developed for the adjunc | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Lacosamide 175481-36-4
| 產(chǎn)品描述 | |
| 描述 | Lacosamide (Vimpat; Erlosamide) is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. |
| 純度 | 98% |
| 儲(chǔ)存/保存方法 | Lacosamide Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 可溶性/溶解性 | 10 mM in DMSO |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) |
|
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢(xún)
